Cohortias
Mexico City, Mexico· Est.
Latin‑America‑focused CRO delivering cost‑effective, full‑service clinical trial solutions with low patient loss‑to‑follow‑up.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Latin‑America‑focused CRO delivering cost‑effective, full‑service clinical trial solutions with low patient loss‑to‑follow‑up.
OncologyOphthalmologyDiabetesInfectious DiseasesCardiovascularNeurologyRespiratory
Technology Platform
Proprietary operational framework that combines a dense local site network, cloud‑based data capture, and streamlined regulatory pathways to deliver end‑to‑end CRO services across Latin America.
Opportunities
Growing demand for cost‑effective, diverse patient enrollment in Latin America and the firm’s low loss‑to‑follow‑up rate position it to capture increasing sponsor spend in the region.
Risk Factors
Regulatory variability across LATAM countries and competition from global CROs expanding their local presence could pressure margins and market share.
Competitive Landscape
Competes with multinational CROs such as IQVIA, PPD, and ICON, as well as regional players; differentiates through deep local site networks, rapid start‑up times, and a proven low patient dropout record.